Key Points

  • A nationwide recall was issued for mirabegron tablets due to an impurity in the active ingredient.

  • The recall is classified as Class II, meaning it may cause temporary or reversible health effects.

  • Check your medication and contact your pharmacy for a refund or replacement if you have the recalled product.

There’s an ongoing recall on a specific type of bladder medication distributed and prescribed nationwide, according to the U.S. Food and Drug Administration (FDA). This is due to an impurity issue.

The medication being recalled is 25-milligram, 30-count bottles of mirabegron extended-release tablets manufactured by Zydus Lifesciences. The recalled bottles contain a lot code of “E408618,” an NDC of “70710-1159-3” and the expiration date “11/30/2026.”

The bladder medication, prescribed to treat overactive bladder symptoms, is being recalled due to an out-of-specification test result that confirmed an impurity for the active ingredient mirabegron. Therefore, this recall has been classified as Class II, meaning that taking these pills may cause “temporary or medically reversible adverse health consequences.”

Check your medication, and if you have the recalled product on hand, contact your pharmacy for a refund or replacement. Seek medical attention if you are experiencing any health concerns after consuming the affected pills.

For questions about this recall, contact the FDA by calling 1-888-INFO-FDA (1-888-463-6332).

Read the original article on EatingWell